Milestone Scientific (NYSE:MLSS) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSSFree Report) in a report published on Saturday. The firm issued a hold rating on the stock.

Separately, Benchmark restated a “speculative buy” rating and set a $1.25 target price on shares of Milestone Scientific in a research report on Wednesday, November 20th.

Read Our Latest Research Report on Milestone Scientific

Milestone Scientific Trading Down 1.7 %

Shares of NYSE MLSS opened at $0.91 on Friday. The company has a 50 day simple moving average of $1.13 and a two-hundred day simple moving average of $0.96. The stock has a market cap of $70.88 million, a price-to-earnings ratio of -13.00 and a beta of 1.41. Milestone Scientific has a 12 month low of $0.54 and a 12 month high of $1.39.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Y Intercept Hong Kong Ltd acquired a new stake in shares of Milestone Scientific during the 3rd quarter worth approximately $48,000. Geode Capital Management LLC grew its position in Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after buying an additional 31,572 shares during the period. World Investment Advisors LLC acquired a new stake in Milestone Scientific during the third quarter valued at $91,000. Carnegie Investment Counsel increased its holdings in Milestone Scientific by 18.9% in the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock valued at $166,000 after buying an additional 27,412 shares in the last quarter. Finally, Renaissance Technologies LLC raised its position in shares of Milestone Scientific by 72.8% in the fourth quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock worth $121,000 after acquiring an additional 53,198 shares during the period. 5.79% of the stock is currently owned by hedge funds and other institutional investors.

About Milestone Scientific

(Get Free Report)

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.

See Also

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.